Gary E. Raskob

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen et al. · New England Journal of Medicine · 2013 · 2.3K citations · Full text

Medicine, Pharmacokinetics, Pharmacotherapy +12

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Gary E. Raskob, Nick van Es, Peter Verhamme et al. · New England Journal of Medicine · 2017 · 1.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement

Michael R. Lassen, Alexander Gallus, Gary E. Raskob et al. · New England Journal of Medicine · 2010 · 775 citations

Medicine, Pharmacology, Pharmacotherapy +17

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

Harry R. Büller, Claudette Bethune, Sanjay Bhanot et al. · New England Journal of Medicine · 2014 · 622 citations · Full text

Medicine, Hematology, Molecular Genetics +11

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Harry R. Büller, Anthonie W.A. Lensing, Martin H. Prins et al. · Blood · 2008 · 345 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12